ATP13A2 Gene PARK9 Parkinson NGS Genetic DNA Test
Comprehensive Genetic Testing for Parkinson’s Disease
The ATP13A2 Gene PARK9 Parkinson NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering unprecedented insights into Parkinson’s disease risk and management. This advanced test specifically targets the ATP13A2 gene, which plays a critical role in cellular function and has been directly linked to Parkinson’s disease development. Using state-of-the-art Next-Generation Sequencing technology, our test provides comprehensive analysis of genetic variations that could impact your neurological health.
What Does This Test Measure and Detect?
This specialized genetic test focuses on identifying mutations and variations in the ATP13A2 gene, which encodes a lysosomal type 5 P-type ATPase. The test detects:
- Pathogenic variants associated with PARK9-linked Parkinsonism
- Single nucleotide polymorphisms (SNPs) affecting gene function
- Copy number variations impacting gene expression
- Novel mutations that may contribute to disease risk
- Genetic markers for early-onset Parkinson’s disease
Who Should Consider This Test?
This genetic screening is particularly recommended for individuals experiencing:
- Early-onset movement disorders (before age 50)
- Family history of Parkinson’s disease or related neurological conditions
- Unexplained tremors, rigidity, or bradykinesia
- Progressive neurological symptoms without clear diagnosis
- Planning for family and concerned about genetic inheritance
- Current Parkinson’s disease diagnosis seeking genetic confirmation
Key Benefits of Genetic Testing
Undergoing the ATP13A2 genetic test provides numerous advantages:
- Early Detection: Identify genetic risk factors before symptom onset
- Personalized Treatment: Tailor medication and therapy based on genetic profile
- Family Planning: Make informed decisions about genetic inheritance
- Proactive Management: Implement preventive strategies and lifestyle modifications
- Peace of Mind: Reduce uncertainty about neurological health risks
- Research Contribution: Advance scientific understanding of Parkinson’s genetics
Understanding Your Test Results
Your genetic test results will be carefully analyzed and presented with comprehensive guidance:
- Positive Result: Indicates presence of ATP13A2 mutations associated with increased Parkinson’s risk
- Negative Result: No detected mutations in the analyzed gene regions
- Variant of Uncertain Significance: Genetic changes requiring further investigation
- Carrier Status: Information about genetic inheritance patterns
All results include detailed interpretation by our certified genetic counselors and neurologists, ensuring you receive personalized recommendations for next steps.
Test Pricing Information
| Test Name | Discount Price | Regular Price |
|---|---|---|
| ATP13A2 Gene PARK9 Parkinson NGS Genetic DNA Test | $500 USD | $700 USD |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified collection centers ensures accessible genetic testing for everyone.
Take Control of Your Neurological Health Today
Don’t wait to gain crucial insights into your genetic risk for Parkinson’s disease. Our ATP13A2 genetic test provides the information you need to make informed healthcare decisions and take proactive steps toward maintaining neurological wellness.
Call or WhatsApp us now at +1(267) 388-9828 to schedule your test or speak with our genetic counseling team. Early detection could make all the difference in managing your neurological health effectively.
Note: Test results are typically available within 3-4 weeks. Sample collection options include blood draw, extracted DNA, or one drop of blood on FTA card. Pre-test genetic counseling is recommended to discuss family history and testing implications.
